Package 42543-719-04

{"route": ["ORAL"], "spl_id": "427e3960-fb3a-429d-8651-b62e7b97479d", "openfda": {"nui": ["N0000175462", "M0015066", "N0000009947"], "upc": ["0342543719040"], "unii": ["G70B4ETF4S", "OTT9J7900I"], "rxcui": ["476556"], "spl_set_id": ["7ecc604c-c4b4-4419-a733-ecb11662fc81"], "pharm_class_cs": ["Nucleosides [CS]"], "pharm_class_epc": ["Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "manufacturer_name": ["Strides Pharma Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE, PLASTIC (42543-719-04)", "package_ndc": "42543-719-04", "marketing_start_date": "20210330"}], "brand_name": "Emtricitabine and Tenofovir Disoproxil Fumarate", "product_id": "42543-719_427e3960-fb3a-429d-8651-b62e7b97479d", "dosage_form": "TABLET", "pharm_class": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Nucleosides [CS]", "Nucleosides [CS]"], "product_ndc": "42543-719", "generic_name": "EMTRICITABINE and TENOFOVIR Disoproxil Fumarate", "labeler_name": "Strides Pharma Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Emtricitabine and Tenofovir Disoproxil Fumarate", "active_ingredients": [{"name": "EMTRICITABINE", "strength": "200 mg/1"}, {"name": "TENOFOVIR DISOPROXIL FUMARATE", "strength": "300 mg/1"}], "application_number": "ANDA091055", "marketing_category": "ANDA", "marketing_start_date": "20210330", "listing_expiration_date": "20261231"}